<DOC>
	<DOCNO>NCT01061567</DOCNO>
	<brief_summary>The general aim non-interventional study ass safety efficacy pramipexole extend release patient Parkinson 's disease routine clinical practice .</brief_summary>
	<brief_title>Assessment Safety Efficacy Pramipexole Extended Release Patients With Parkinson 's Disease Routine Clinical Practice</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Pramipexole</mesh_term>
	<criteria>Inclusion criterion : Early advance idiopathic Parkinson 's disease Male female patient 18 year age Indication treatment pramipexole ER accord Summary Product Characteristics ( SmPC ) Exclusion criterion : Ongoing treatment pramipexole ER Exclusion criterion line pramipexole ER SmPC : In particular hypersensitivity pramipexole excipients pregnancy lactation state SmPC .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>